AIP
SLDB icon

Ameritas Investment Partners’s Solid Biosciences SLDB Stock Holding History

Ameritas Investment Partners’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.3K Buy
7,142
+2,216
+45% +$16.8K ﹤0.01% 2030
2026
Q1 		$35.5K Hold
4,926
– – ﹤0.01% 2295
2025
Q4 		$27.8K Hold
4,926
– – ﹤0.01% 2481
2025
Q3 		$30.4K Sell
4,926
-1,814
-27% -$10.6K ﹤0.01% 2477
2025
Q2 		$32.8K Buy
6,740
+4,534
+206% +$16K ﹤0.01% 2444
2025
Q1 		$8.16K Hold
2,206
– – ﹤0.01% 2880
2024
Q4 		$8.82K Hold
2,206
– – ﹤0.01% 2932
2024
Q3 		$15.4K Hold
2,206
– – ﹤0.01% 2767
2024
Q2 		$12.5K Buy
+2,206
New +$19.8K ﹤0.01% 2840
2022
Q2 		– Sell
-315
Closed -$6K – 3215
2022
Q1 		$6K Hold
315
– – ﹤0.01% 2937
2021
Q4 		$8K Hold
315
– – ﹤0.01% 2966
2021
Q3 		$11K Hold
315
– – ﹤0.01% 2918
2021
Q2 		$17K Buy
315
+158
+101% +$10.4K ﹤0.01% 2821
2021
Q1 		$13K Hold
157
– – ﹤0.01% 2752
2020
Q4 		$18K Buy
157
+90
+134% +$5.69K ﹤0.01% 2526
2020
Q3 		$2K Hold
67
– – ﹤0.01% 3071
2020
Q2 		$3K Hold
67
– – ﹤0.01% 3027
2020
Q1 		$2K Hold
67
– – ﹤0.01% 2970
2019
Q4 		$4K Hold
67
– – ﹤0.01% 2928
2019
Q3 		$10K Hold
67
– – ﹤0.01% 2759
2019
Q2 		$6K Hold
67
– – ﹤0.01% 2928
2019
Q1 		$9K Hold
67
– – ﹤0.01% 2734
2018
Q4 		$27K Hold
67
– – ﹤0.01% 2165
2018
Q3 		$47K Buy
67
+16
+31% +$10.1K ﹤0.01% 2025
2018
Q2 		$27K Hold
51
– – ﹤0.01% 2340
2018
Q1 		$6K Buy
+51
New +$17.2K ﹤0.01% 2834

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameritas Investment Partners's SLDB Position: Q2 2026 in Review

Ameritas Investment Partners increased its Solid Biosciences (SLDB) stake by 45% in Q2 2026, buying an estimated $16.8K and bringing the position to 7,142 shares worth $71.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Ameritas Investment Partners first reported a position in SLDB in Q1 2018 and has held it in 26 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Ameritas Investment Partners held 7,142 shares of Solid Biosciences worth $71.3K as of Q2 2026.
  • Ameritas Investment Partners bought 2,216 Solid Biosciences shares in Q2 2026, an estimated $16.8K.
  • Solid Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2030 holding.
  • Ameritas Investment Partners first reported a position in Solid Biosciences in Q1 2018 and has held it in 26 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.